Pfizer reported strong financial performance in the 4th quarter of 2011, meeting or exceeding their annual financial guidance. Their revenue was boosted by their blockbuster drug Viagra and efforts to slim down and restructure the company. For 2011, Pfizer returned over $15 billion to shareholders through dividends and share repurchases, demonstrating solid financial results.